Carboxy Therapy Market Introduction

The cutaneous as well as subcutaneous administration of carbon dioxide gas for therapeutic purposes is referred to as carboxy therapy. Originally, this therapy was innovated at the Royal Spas of France in the year 1932 for treatment of patients affected by peripheral arterial occlusive disease. In regions such as South America and Europe, carbon dioxide therapy is being applied for the treatment of stretch marks, cellulite, and hypertrophic scars and the results have been reported to be impressive. Varied number of studies have confirmed that carboxy therapy helps to improve elasticity of skin, improves blood circulation, boosts collagen repair, mends the appearance of fine lines or wrinkles, and abolishes localized fatty deposits.

Carboxy Therapy Market Competitive Landscape

Merz Pharma GmbH & Co. KGaA

Merz Pharma engages in the development, research, and sale of innovative medical drugs and products for neurological and clinical dermatological purposes. The company operates in the market through its aesthetics and neurotoxins products, which are driving the company towards innovation and strategic acquisitions.

Identify the key factors that will drive your company’s growth, Request a brochure of this report here

Fosun Pharmaceutical Co., Ltd.

The company operates in the medical aesthetic devices business through its subsidiary Alma Lasers Ltd. Fosun Pharma is a business segment of Fosun International Ltd., and a leading health care company in China listed on the SSE and the Hong Kong Stock Exchange. Its subsidiary Alma Lasers is a global developer and provider of laser, light-based, radio-frequency, and ultrasound solutions for the aesthetic and surgical markets.

Allergan plc

Allergan plc engages in the development, manufacture, and marketing of branded pharmaceuticals, devices, and biologic products. The company has presence in over 100 countries, holding top five positions in nearly 20 international markets

Carboxy Therapy Market Dynamics

Growth of Elderly population

The elderly population is one of the major growth drivers for the carboxy therapy market. According to the United Nations, the rate of population ageing in the 21st century is likely to exceed that of the previous century. Between 2015 and 2030, the number of people in the world aged 60 years or above is projected to rise from 901 million to 1.4 billion, an increase by 56%. By 2050, the global elderly population is estimated to more than double its size in 2015, reaching nearly 2.1 billion. This growth of geriatric population continues to lead to a shift toward developing new treatments to reverse the aging process.

Increasing Demand for Minimally Invasive Facial Rejuvenation Treatment

According to the International Society of Aesthetic Plastic Surgery (ISAPS), around 12.1 million non-surgical cosmetic procedures were performed in 2015 worldwide. The increasing demand for non-invasive treatments would propel the market of carboxy therapy during the forecast period.

For simple skin-related problems such as wrinkles, lines, and unwanted hair; patients prefer quicker solutions with minimal pains, which help them resume their duties at the earliest. Patients prefer carboxy therapy, as they involve no side-effects and shorter recovery time.

Expanding operations in future? To get the perfect launch ask for a custom report here

Decrease in Social Taboos Boosting Acceptance of Aesthetics Treatment

Reduction in cultural prohibitions and social taboos is a key factor for increase in the number of aesthetic procedures across the world. Rise in social consciousness about the importance of personal appearance and personality development is another major factor driving the global medical aesthetic devices market.

Carboxy Therapy Market Segmentation

Based on the type, the carboxy therapy market is segmented into

  • Table-top
  • Portable
  • Others

Based on the route of administration, the carboxy therapy market is segmented into

  • Subcutaneous
  • Epicutaneous
  • Others

Based on the application, the carboxy therapy market is segmented into

  • Angiology
  • Orthopedics & rheumatology
  • Urology
  • Endocrinology
  • Gynecology
  • Cosmetology
  • Others

Based on end-users, the carboxy therapy market is segmented into

  • Hospitals
  • Clinics
  • Beauty Centers
  • Others

The report on carboxy therapy market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The carboxy therapy market report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The carboxy therapy market report also maps the qualitative impact of various market factors on market segments and geographies.    

Regional analysis for carboxy therapy market includes:

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)
  • Latin America

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.